Enhanced cytotoxicity of a polymer-drug conjugate with triple payload of paclitaxel

被引:62
|
作者
Erez, Rotem [1 ]
Segal, Ehud [2 ]
Miller, Keren [2 ]
Satchi-Fainaro, Ronit [2 ]
Shabat, Doron [1 ]
机构
[1] Tel Aviv Univ, Raymond & Beverly Sackler Fac Exact Sci, Sch Chem, Dept Organ Chem, IL-69978 Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med Sci, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel
关键词
Prodrug; Conjugate; HPMA copolymer; Self-immolative; Paclitaxel; Polymer therapeutics; ENZYME PRODRUG THERAPY; SELF-IMMOLATIVE DENDRIMERS; HPMA COPOLYMER; ANTICANCER AGENTS; MODEL COMBINATION; NANOMEDICINES; ANGIOGENESIS; DOCETAXEL; TNP-470; CANCER;
D O I
10.1016/j.bmc.2009.05.028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The development of targeting approaches to selectively release chemotherapeutic drugs into malignant tissue is a major challenge in anticancer therapy. We have synthesized an N-(2-hydroxypropyl)-methacrylamide (HPMA) copolymer-drug conjugate with an AB(3) self-immolative dendritic linker. HPMA copolymers are known to accumulate selectively in tumors. The water-soluble polymer-drug conjugate was designed to release a triple payload of the hydrophobic drug paclitaxel as a result of cleavage by the endogenous enzyme cathepsin B. The polymer-drug conjugate exhibited enhanced cytotoxicity on murine prostate adenocarcinoma (TRAMP C2) cells in comparison to a classic monomeric drug-polymer conjugate. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4327 / 4335
页数:9
相关论文
共 50 条
  • [31] Well-defined diblock brush polymer-drug conjugates for sustained delivery of paclitaxel
    Zou, Jiong
    Yu, Yun
    Li, Yukun
    Ji, Wei
    Chen, Chih-Kuang
    Law, Wing-Cheung
    Prasad, Paras N.
    Cheng, Chong
    BIOMATERIALS SCIENCE, 2015, 3 (07) : 1078 - 1084
  • [32] Antiviral polymer-drug conjugates
    不详
    MATERIALWISSENSCHAFT UND WERKSTOFFTECHNIK, 2008, 39 (01) : A5 - A5
  • [33] Covalent polymer-drug conjugates
    Elvira, C
    Gallardo, A
    San Roman, J
    Cifuentes, A
    MOLECULES, 2005, 10 (01) : 114 - 125
  • [34] Enzyme-activatable polymer-drug conjugate augments tumour penetration and treatment efficacy
    Zhou, Quan
    Shao, Shiqun
    Wang, Jinqiang
    Xu, Changhuo
    Xiang, Jiajia
    Piao, Ying
    Zhou, Zhuxian
    Yu, Qingsong
    Tang, Jianbin
    Liu, Xiangrui
    Gan, Zhihua
    Mo, Ran
    Gu, Zhen
    Shen, Youqing
    NATURE NANOTECHNOLOGY, 2019, 14 (08) : 799 - +
  • [35] PMSE 446-Architecture of polymer-drug conjugate controls in vivo fate and efficacy
    Chilkoti, Ashutosh
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [36] pH-Responsive Polymer-Drug Conjugate: An Effective Strategy to Combat the Antimicrobial Resistance
    Ye, Mingzhou
    Zhao, Yi
    Wang, Yuyuan
    Yodsanit, Nisakorn
    Xie, Ruosen
    Gong, Shaoqin
    ADVANCED FUNCTIONAL MATERIALS, 2020, 30 (39)
  • [37] Synthesis and properties of a biodegradable polymer-drug conjugate: Methotrexate-poly(glycerol adipate)
    Suksiriworapong, Jiraphong
    Taresco, Vincenzo
    Ivanov, Delyan P.
    Styliari, Ioanna D.
    Sakchaisri, Krisada
    Junyaprasert, Varaporn Buraphacheep
    Garnett, Martin C.
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2018, 167 : 115 - 125
  • [38] PMSE 206-Architecture of polymer-drug conjugate controls in vivo fate and efficacy
    Chilkoti, Ashutosh
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 235
  • [39] Polymer-Drug Conjugates for Anticancer Drug Delivery
    Wadhwaa, Saurabh
    Mumper, Russell J.
    CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2015, 32 (03): : 215 - 245
  • [40] Innovative Design of Targeted Nanoparticles: Polymer-Drug Conjugates for Enhanced Cancer Therapy
    Junyaprasert, Varaporn Buraphacheep
    Thummarati, Parichart
    PHARMACEUTICS, 2023, 15 (09)